Related Experiment Video
Updated: Jan 19, 2026
Hepatic Drug Clearance: Effect of Protein Binding
Vaspin is a novel target gene of hepatic CCAAT-enhancer-binding protein
Daisuke Aibara1, Kohei Matsuo1, Shigeru Yamano1
1Faculty of Pharmaceutical Science, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
Abstract:
Vaspin, initially identified in visceral adipose tissue, is an adipokine, and administration of recombinant vaspin leads to lowering of the endoplasmic reticulum stress which is elevated in obesity or enhancement of insulin sensitivity. CCAAT/enhancer binding protein (C/EBP), as a basic leucine zipper transcription factor, plays a critical role in adipocyte development and glucose and lipid metabolisms in liver. The present study aimed to investigate the effect of C/EBPα on vaspin gene expression. The expression of hepatic vaspin was markedly decreased in liver-specific C/EBPα knockout mice. A reporter assay indicated that two C/EBP-responsive elements (CEBPREs) are necessary for C/EBPα-dependent induction of vaspin promoter activities. Furthermore, electrophoretic mobility shift assay showed that C/EBPα in mouse liver is capable of directly binding the two CEBPREs. These results suggest that C/EBPα positively regulates hepatic vaspin expression through two functional CEBPREs. Thus, vaspin is a novel C/EBPα target gene in the liver.
Related Concept Videos
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
07:05Chromatin Immunoprecipitation to Identify Target Protein Binding Sites on Genomic DNA
Recombineering and Gene Targeting
04:46Targeting Liver Tumors with Oncolytic Viruses via the Hepatic Artery
12:13Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells
04:24TALEN-Mediated Targeted Gene Integration: Using Engineered Sequence-Specific Nucleases for the Precise Insertion of Fluorescent Protein Gene into hiPSCs
